New Therapies on the Horizon for Relapsed Refractory Multiple Myeloma

Nadine Abdallah; Shaji K. Kumar

doi:10.1016/j.hoc.2023.12.013

New Therapies on the Horizon for Relapsed Refractory Multiple Myeloma

Hematology

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	511-532
Number of pages	22
Journal	Hematology/Oncology Clinics of North America
Volume	38
Issue number	2
DOIs	https://doi.org/10.1016/j.hoc.2023.12.013
State	Published - Apr 2024

Keywords

Iberdomide
Mezigdomide
Modakafusp alfa
Venetoclax

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1016/j.hoc.2023.12.013

Cite this

@article{20306526e6b941568d3cee668ee08ffe,

title = "New Therapies on the Horizon for Relapsed Refractory Multiple Myeloma",

keywords = "Iberdomide, Mezigdomide, Modakafusp alfa, Venetoclax",

author = "Nadine Abdallah and Kumar, {Shaji K.}",

year = "2024",

month = apr,

doi = "10.1016/j.hoc.2023.12.013",

language = "English (US)",

volume = "38",

pages = "511--532",

journal = "Hematology/Oncology Clinics of North America",

issn = "0889-8588",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - New Therapies on the Horizon for Relapsed Refractory Multiple Myeloma

AU - Abdallah, Nadine

AU - Kumar, Shaji K.

PY - 2024/4

Y1 - 2024/4

KW - Iberdomide

KW - Mezigdomide

KW - Modakafusp alfa

KW - Venetoclax

UR - http://www.scopus.com/inward/record.url?scp=85182378959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85182378959&partnerID=8YFLogxK

U2 - 10.1016/j.hoc.2023.12.013

DO - 10.1016/j.hoc.2023.12.013

M3 - Review article

C2 - 38216384

AN - SCOPUS:85182378959

SN - 0889-8588

VL - 38

SP - 511

EP - 532

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

IS - 2

ER -

New Therapies on the Horizon for Relapsed Refractory Multiple Myeloma

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this